New York City - Events at Quotient Sciences

DCAT 2025

New York City, United States | 17 March 2025 - 20 March 2025
Overview

Join our drug product and commercial manufacturing experts in New York City for DCAT Week 2025.

Quotient Sciences Drug Development Consultants will be participating in partnering meetings throughout the week to learn more about your drug development program and share updates on our expanded capabilities. We are ready to hear about your challenges and share with you how partnering with Quotient Sciences can accelerate your timeline.  

We will be hosting meetings at The Fifty Sonesta Hotel in Suites 2101 and 2201

Schedule a meeting with our team today to discuss your drug program's needs for 2025 and beyond. 

For more information or assistance, you can also contact us directly by emailing events@quotientsciences.com.

Register
Location
The Fifty Sonesta Hotel in Suites 2101 and 2201
New York City, United States

Meet our Experts:

We look forward to meeting you at DCAT 2025.

Dr. Andrew Lewis

Chief Scientific Officer

Dr. Andrew (Andy) Lewis is the Chief Scientific Officer at Quotient Sciences. As the leader of Quotient Sciences' scientific teams...

About Andrew
Dr. Vanessa Zann

VP Scientific Consulting, TP-CP USA

Dr. Vanessa Zann is an Executive Drug Development Consultant at Quotient Sciences, with over twenty-five years industry experience...

About Vanessa
Brad Rowe

Senior Director, Integrated Development

Brad Rowe is a Senior Director, Integrated Development at Quotient Sciences, based from our Philadelphia, PA sites in Garnet Valle...

About Brad
Katie Stuart

Executive Director & Head of Commercial TP-CP USA

About Katie
Jamie Weishaar

VP, Global Commercial Drug Product

Jamie Weishaar is an experienced Business Development Executive leader specializing in Pharmaceutical Drug Development, including ...

Contact Us
Robert Cornog

Senior Director, Product Development

Robert Cornog has over 26 years of experience in product development and process design, across a broad range of dosage forms and ...

About Robert
Jeff Folks

Sr Director Development Director

Jeff Folks is an experienced Business Development leader specializing in Pharmaceutical Drug Product Development and Manufacturing...

About Jeff
Eric Bironneau

Chief Business Officer

Eric Bironneau has joined the company as Chief Business Officer, with responsibility for Quotient Sciences’ commercial organizatio...

About Eric

More insight from our experts:

Read More
Translational Pharmaceutics, Denise Sutton, Nottingham Spotlight on Nottingham: Q&A with Denise Sutton, Chief Operating Officer and Site Head - Nottingham, UK – Part 2 By: Denise Sutton
Read More
Translational Pharmaceutics, Denise Sutton, Nottingham Spotlight on Nottingham: Q&A with Denise Sutton, Chief Operating Officer and Site Head - Nottingham, UK – Part 1 By: Denise Sutton
Read More
Drug Substance, Translational Pharmaceutics, Dr. Richard Castledine Understanding the Complexity of Psychedelic Drug Development: Key Takeaways and Considerations for Drug Developers By: Dr. Richard Castledine
Read More
Read More